Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,680.09
(
-0.54%
)
US TECH 100
23,978.40
(
-0.64%
)
Dow Jones
46,607.64
(
-0.82%
)
Brent Oil
106.01
(
5.33%
)
Bitcoin
71,201.09
(
-3.72%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

microcapfun

Send PM Follow Ignore
Followers 6
Posts 560
Boards Moderated 0
Alias Born 03/13/2007

microcapfun

Re: DewDiligence post# 54354

Wednesday, 11/07/2007 10:50:51 PM

Wednesday, November 07, 2007 10:50:51 PM

Post# of 257253
OctoPlus, Biolex Report More Color on Phase-2a Locteron Data

I guess the main advantages that HGS has at this point are a ~3 year head start (assuming OctoPlus+Biolex carry out a P2b trial after their P2a trial) and Novartis as a marketing partner.

micro

Life is an IQ test.

email: microcapfun@yahoo.com

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now